The present study was designed to test whether RGZ alters hepatic Sirt1 and whether Sirt1 and/or Sirt6 have a regulatory role in the protective effects of rosiglitazone (RGZ) on hepatocyte steatosis. Here, SIRT1 is linked to steatosis.